Abstract
Aim:
To investigate the biotransformation of metoprolol, a β1-cardioselective adrenoceptor antagonist, by filamentous fungus, and to compare the parallels between microbial transformation and mammalian metabolism.
Methods:
Five strains of Cunninghamella (C elegans AS 3.156, C elegans AS 3.2028, C echinulata AS 3.2004, C blakesleeana AS 3.153 and AS 3.910) were screened for the ability to transform metoprolol. The metabolites of metoprolol produced by C blakesleeana AS 3.153 were separated and assayed by liquid chromatography-tandem mass spectrometry (LC/MSn). The major metabolites were isolated by semipreparative HPLC and the structures were identified by a combination of LC/MSn and nuclear magnetic resonance analysis.
Results:
Metoprolol was transformed to 7 metabolites; 2 were identified as new metabolites and 5 were known metabolites in mammals.
Conclusion:
The microbial transformation of metoprolol was similar to the metabolism in mammals. The fungi belonging to Cunninghamella species could be used as complementary models for predicting in vivo metabolism and producing quantities of metabolite references for drugs like metoprolol.
Similar content being viewed by others
Article PDF
References
Davis ME, Richards AM, Nicholls MG, Yandle TG, Frampton CM, Troughton RW . Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure. Circulation 2006; 113: 977–85.
Borg KO, Carlsson E, Hoffmann KJ, Jonsson TE, Thorin H, Wallin B . Metabolism of metoprolol (3H) in man, the dog and the rat. Acta Pharmacol Toxicol 1975; 36: 125–35.
Dumasia MC . In vivo biotransformation of metoprolol in horse and on-column esterification of the aminocarboxylic acid metabolite by alcohols during solid phase extraction using mixed mode columns. J Pharm Biomed Anal 2006; 40: 75–81.
Lennard MS, Tucker GT, Woods HF . The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1986; 11: 1–17.
Lisowska K, Szemraj, J, Rozalska S, Dlugonski J . The expression of cytochrome P-450 and cytochrome P-450 reductase genes in the simultaneous transformation of corticosteroids and phenanthrene by Cunninghamella elegans. FEMS Microbiol Lett 2006; 261: 175–80.
Zhang D, Zhang H, Aranibar N, Hanson R, Huang Y, Cheng PT, et al. Structural elucidation of human oxidative metabolites of muragli-tazar: use of microbial bioreactors in the biosynthesis of metabolite standards. Drug Metab Dispos 2006; 34: 267–80.
Lisowska K, Dlugonski J, Freeman JP, Cerniglia CE . The effect of the corticosteroid hormone cortexolone on the metabolites produced during phenanthrene biotransformation in Cunning-hamella elegans. Chemosphere 2006; 64: 1499–506.
Chen Y, Monshouwer M, Fitch WL . Analytical tools and approaches for metabolite identification in early drug discovery. Pharm Res 2007; 24: 248–57.
Sun L, Huang HH, Liu L, Zhong DF . Transformation of verapamil by Cunning hamella blake sleana. Appl Environ Microbial 2004; 70: 2722–7.
Xie ZY, Huang HH, Zhong DF . Biotransformation of pantoprazole by the fungus Cunninghamella blakesleana. Xenobiotica 2005; 35: 467–77.
Zhang P, Lin LH, Huang HH, Xu HY, Zhong DF . Biotransformation of indomethacin by the fungus Cunninghamella blakesleeana. Acta Pharmacol Sin 2006; 27: 1097–102.
Kulkarni VM, Coutinho EC . Conformational analysis of atenolol and metoprolol by 1H NMR. Indian J Chem 1991; 30: 52–6.
de Groot MJ, Ackland MJ, Horne VA, Alex AA, Jones BC . A novel approach to predicting P450-mediated drung metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6. J Med Chem 1999; 42: 4062–70.
Upthagrove AL, Nelson WL . Importance of amine pKa and distribution coefficient in the metabolism of fluorinated propranolol derivatives. Preparation, identification of metabolite regioisomers, and metabolism by CYP2D6. Durg Metab Dispos 2001; 29: 1377–88.
Bonde J, Bodtker S, Angelo HR, Svendsen TL, Kampmann JP . Atenolol inhibits the elimination of disopyramide. Eur J Clin Pharmacol 1985; 28: 41–3.
Zamek-Gliszcynski MJ, Hoffmaster KA, Nezasa K, Tallman MN, Brouwer KL . Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur J Pharm Sci 2006; 27: 447–86.
Levsen K, Schiebel HM, Behnke B, Dotzer R, Dreher W, Elend M, et al. Structure elucidation of phase II metabolites by tandem mass spectrometry: on overview: J Chromatogr A 2005; 1067: 55–72.
Huang HH, Ma GL, Sun YM, Li Q, Zhong DF . Phase II metabolites of etofesalamide in filamentous fungi. Acta Pharmacol Sin 2005; 26: 893–6.
Zhan J, Gunatilaka AA . Microbial transformation of curvularin. J Nat Prod 2005; 68: 1271–3.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ma, B., Huang, Hh., Chen, Xy. et al. Biotransformation of metoprolol by the fungus Cunninghamella blakesleeana. Acta Pharmacol Sin 28, 1067–1074 (2007). https://doi.org/10.1111/j.1745-7254.2007.00567.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00567.x
Keywords
This article is cited by
-
Non-antifungal drugs inhibit growth, morphogenesis and biofilm formation in Candida albicans
The Journal of Antibiotics (2021)
-
Studies on the metabolism of five model drugs by fungi colonizing cadavers using LC-ESI-MS/MS and GC-MS analysis
Analytical and Bioanalytical Chemistry (2012)